{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:52:54Z","timestamp":1792759974820,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Biol"],"DOI":"10.1186\/s13059-026-03974-7","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T05:45:19Z","timestamp":1770011119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Functional correction and genome integrity with duplex base editing of \u03b2-thalassemic hematopoietic stem cells"],"prefix":"10.1186","volume":"27","author":[{"given":"Nikoletta Y.","family":"Papaioannou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Patsali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Klermund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiota L.","family":"Papasavva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffroy","family":"Andrieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lola","family":"Koniali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma","family":"Naiisseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soteroula","family":"Christou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sitarou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Kleanthous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Cathomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten W.","family":"Lederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"3974_CR1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.hoc.2019.01.003","volume":"33","author":"E Khandros","year":"2019","unstructured":"Khandros E, Kwiatkowski JL. Beta thalassemia: monitoring and new treatment approaches. Hematol Oncol Clin North Am. 2019;33:339\u201353. https:\/\/doi.org\/10.1016\/j.hoc.2019.01.003.","journal-title":"Hematol Oncol Clin North Am"},{"key":"3974_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/ajts.AJTS_71_16","volume":"14","author":"D Chandra Sharma","year":"2020","unstructured":"Chandra Sharma D, Singhal S, Woike P, Rai S, Yadav M, Gaur R. Hereditary persistence of fetal hemoglobin. Asian J Transfus Sci. 2020;14:185\u20136. https:\/\/doi.org\/10.4103\/ajts.AJTS_71_16.","journal-title":"Asian J Transfus Sci"},{"key":"3974_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/J.HEMONC.2017.09.003","volume":"12","author":"A Sokolova","year":"2019","unstructured":"Sokolova A, Mararenko A, Rozin A, Podrumar A, Gotlieb V. Hereditary persistence of hemoglobin F is protective against red cell sickling. A case report and brief review. Hematol Oncol Stem Cell Ther. 2019;12:215\u20139. https:\/\/doi.org\/10.1016\/J.HEMONC.2017.09.003.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"3974_CR4","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2018.122","author":"M Cavazzana","year":"2018","unstructured":"Cavazzana M, Mavilio F. Gene therapy for hemoglobinopathies. Hum Gene Ther. 2018. https:\/\/doi.org\/10.1089\/hum.2018.122.","journal-title":"Hum Gene Ther"},{"key":"3974_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cells12242848","volume":"12","author":"L Koniali","year":"2023","unstructured":"Koniali L, Flouri C, Kostopoulou MI, Papaioannou NY, Papasavva PL, Naiisseh B, et al. Evaluation of mono- and bi-functional GLOBE-based vectors for therapy of \u03b2-thalassemia by HBBAS3 gene addition and mutation-specific RNA interference. Cells. 2023;12:2848. https:\/\/doi.org\/10.3390\/cells12242848.","journal-title":"Cells"},{"key":"3974_CR6","unstructured":"ZYNTEGLO | FDA. https:\/\/www.fda.gov\/vaccines-blood-biologics\/zynteglo. Accessed 21 Jul 2024."},{"key":"3974_CR7","unstructured":"Bluebird Bio FDA AdCom Your Viral Vector\u2019s Future Is In The Eye Of The Beholder. https:\/\/www.cellandgenecollaborative.com\/doc\/bluebird-bio-fda-adcom-your-viral-vector-s-future-is-in-the-eye-of-the-beholder-0001. Accessed 1 Aug 2024."},{"key":"3974_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/J.MRGENTOX.2024.503767","volume":"896","author":"M Lemmens","year":"2024","unstructured":"Lemmens M, Dorsheimer L, Zeller A, Dietz-Baum Y. Non-clinical safety assessment of novel drug modalities: genome safety perspectives on viral-, nuclease- and nucleotide-based gene therapies. Mutat Res Genet Toxicol Environ Mutagen. 2024;896:503767. https:\/\/doi.org\/10.1016\/J.MRGENTOX.2024.503767.","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"issue":"337","key":"3974_CR9","first-page":"816","volume":"2012","author":"M Jinek","year":"1979","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 1979;2012(337):816\u201321.","journal-title":"Science"},{"key":"3974_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-28244-5","volume":"13","author":"I H\u00f6ijer","year":"2022","unstructured":"H\u00f6ijer I, Emmanouilidou A, \u00d6stlund R, van Schendel R, Bozorgpana S, Tijsterman M, et al. CRISPR-Cas9 induces large structural variants at on-target and off-target sites in vivo that segregate across generations. Nat Commun. 2022;13:1\u201310. https:\/\/doi.org\/10.1038\/s41467-022-28244-5.","journal-title":"Nat Commun"},{"key":"3974_CR11","doi-asserted-by":"publisher","unstructured":"Fiumara M, Ferrari S, Omer-Javed A, Beretta S, Albano L, Canarutto D, et al. Correction to: Genotoxic effects of base and prime editing in human hematopoietic stem cells. Nat Biotechnol. 2024;42(6):877-891. https:\/\/doi.org\/10.1038\/s41587-023-01915-4. Nat Biotechnol 2024;42:986. https:\/\/doi.org\/10.1038\/S41587-024-02142-1.","DOI":"10.1038\/s41587-023-01915-4"},{"issue":"12","key":"3974_CR12","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","volume":"19","author":"HA Rees","year":"2018","unstructured":"Rees HA, Liu DR. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat Rev Genet. 2018;19(12):770\u201388. https:\/\/doi.org\/10.1038\/s41576-018-0059-1.","journal-title":"Nat Rev Genet"},{"key":"3974_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. 2016;533:420\u20134. https:\/\/doi.org\/10.1038\/nature17946.","journal-title":"Nature"},{"key":"3974_CR14","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, et al. Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature. 2017;551:464\u201371. https:\/\/doi.org\/10.1038\/nature24644.","journal-title":"Nature"},{"key":"3974_CR15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41588-018-0085-0","volume":"50","author":"GE Martyn","year":"2018","unstructured":"Martyn GE, Wienert B, Yang L, Shah M, Norton LJ, Burdach J, et al. Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding. Nat Genet. 2018;50:498\u2013503. https:\/\/doi.org\/10.1038\/s41588-018-0085-0.","journal-title":"Nat Genet"},{"key":"3974_CR16","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41591-019-0401-y","volume":"25","author":"Y Wu","year":"2019","unstructured":"Wu Y, Zeng J, Roscoe BP, Liu P, Yao Q, Lazzarotto CR, et al. Highly efficient therapeutic gene editing of human hematopoietic stem cells. Nat Med. 2019;25:776\u201383. https:\/\/doi.org\/10.1038\/s41591-019-0401-y.","journal-title":"Nat Med"},{"key":"3974_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41591-020-0790-y","volume":"26","author":"J Zeng","year":"2020","unstructured":"Zeng J, Wu Y, Ren C, Bonanno J, Shen AH, Shea D, et al. Therapeutic base editing of human hematopoietic stem cells. Nat Med. 2020;26:535\u201341. https:\/\/doi.org\/10.1038\/s41591-020-0790-y.","journal-title":"Nat Med"},{"key":"3974_CR18","unstructured":"FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease | FDA. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease. Accessed 20 Jul 2024."},{"key":"3974_CR19","unstructured":"First gene editing therapy to treat beta thalassemia and severe sickle cell disease | European Medicines Agency. https:\/\/www.ema.europa.eu\/en\/news\/first-gene-editing-therapy-treat-beta-thalassemia-and-severe-sickle-cell-disease. Accessed 20 Jul 2024."},{"key":"3974_CR20","unstructured":"News: BEAM-101: IND Approval for First Ever Base-Edited Therapy - CRISPR Medicine. https:\/\/crisprmedicinenews.com\/news\/beam-101-ind-approval-for-first-ever-base-edited-therapy\/. Accessed 5 Jul 2024."},{"key":"3974_CR21","doi-asserted-by":"publisher","unstructured":"Zarghamian P, Klermund J, Cathomen T. Clinical genome editing to treat sickle cell disease\u2014A brief update. Front Med (Lausanne). 2022;9. https:\/\/doi.org\/10.3389\/FMED.2022.1065377.","DOI":"10.3389\/FMED.2022.1065377"},{"key":"3974_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/J.BLRE.2024.101185","volume":"65","author":"M Dimitrievska","year":"2024","unstructured":"Dimitrievska M, Bansal D, Vitale M, Strouboulis J, Miccio A, Nicolaides KH, et al. Revolutionising healing: gene editing\u2019s breakthrough against sickle cell disease. Blood Rev. 2024;65:101185. https:\/\/doi.org\/10.1016\/J.BLRE.2024.101185.","journal-title":"Blood Rev"},{"key":"3974_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJPHAR.2022.174788","author":"Y Han","year":"2022","unstructured":"Han Y, Tan X, Jin T, Zhao S, Hu L, Zhang W, et al. CRISPR\/Cas9-based multiplex genome editing of BCL11A and HBG efficiently induces fetal hemoglobin expression. Eur J Pharmacol. 2022. https:\/\/doi.org\/10.1016\/J.EJPHAR.2022.174788.","journal-title":"Eur J Pharmacol"},{"key":"3974_CR24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/J.OMTM.2021.10.008","volume":"23","author":"C Samuelson","year":"2021","unstructured":"Samuelson C, Radtke S, Zhu H, Llewellyn M, Fields E, Cook S, et al. Multiplex CRISPR\/Cas9 genome editing in hematopoietic stem cells for fetal hemoglobin reinduction generates chromosomal translocations. Mol Ther Methods Clin Dev. 2021;23:507\u201323. https:\/\/doi.org\/10.1016\/J.OMTM.2021.10.008.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"3974_CR25","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1182\/blood.2020010020","volume":"138","author":"N Psatha","year":"2021","unstructured":"Psatha N, Georgakopoulou A, Li C, Nandakumar V, Georgolopoulos G, Acosta R, et al. Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo. Blood. 2021;138:1540\u201353. https:\/\/doi.org\/10.1182\/blood.2020010020.","journal-title":"Blood"},{"key":"3974_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061492","volume":"10","author":"L Koniali","year":"2021","unstructured":"Koniali L, Lederer CW, Kleanthous M. Therapy development by genome editing of hematopoietic stem cells. Cells. 2021;10:1492. https:\/\/doi.org\/10.3390\/cells10061492.","journal-title":"Cells"},{"key":"3974_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/JCM10030482","volume":"10","author":"G Frati","year":"2021","unstructured":"Frati G, Miccio A. Genome editing for \u03b2-hemoglobinopathies: advances and challenges. J Clin Med. 2021;10:1\u201317. https:\/\/doi.org\/10.3390\/JCM10030482.","journal-title":"J Clin Med"},{"key":"3974_CR28","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.stem.2021.02.002","volume":"28","author":"G Turchiano","year":"2021","unstructured":"Turchiano G, Andrieux G, Klermund J, Blattner G, Pennucci V, Gaz M, et al. Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq. Cell Stem Cell. 2021;28:1136-1147.e5. https:\/\/doi.org\/10.1016\/j.stem.2021.02.002.","journal-title":"Cell Stem Cell"},{"key":"3974_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/J.JCYT.2022.11.013","volume":"25","author":"WS Lahr","year":"2023","unstructured":"Lahr WS, Sipe CJ, Skeate JG, Webber BR, Moriarity BS. CRISPR-Cas9 base editors and their future role in human therapeutics. Cytotherapy. 2023;25:270. https:\/\/doi.org\/10.1016\/J.JCYT.2022.11.013.","journal-title":"Cytotherapy"},{"key":"3974_CR30","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.65421","volume":"11","author":"NS Ravi","year":"2022","unstructured":"Ravi NS, Wienert B, Wyman SK, Bell HW, George A, Mahalingam G, et al. Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin. Elife. 2022;11:e65421.","journal-title":"Elife"},{"key":"3974_CR31","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1182\/bloodadvances.2019000820","volume":"3","author":"JY M\u00e9tais","year":"2019","unstructured":"M\u00e9tais JY, Doerfler PA, Mayuranathan T, Bauer DE, Fowler SC, Hsieh MM, et al. Genome editing of HBG1 and HBG2 to induce fetal hemoglobin. Blood Adv. 2019;3:3379\u201392. https:\/\/doi.org\/10.1182\/bloodadvances.2019000820.","journal-title":"Blood Adv"},{"key":"3974_CR32","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3324\/haematol.2018.189357","volume":"103","author":"P Patsali","year":"2018","unstructured":"Patsali P, Papasavva P, Stephanou C, Christou S, Sitarou M, Antoniou MN, et al. Short-hairpin RNA against aberrant HBBIVSI-110(G>A) mRNA restores \u03b2-globin levels and acts as mono- and combination therapy for \u03b2-thalassemia in primary hematopoietic stem cells. Haematologica. 2018;103:534\u2013534.","journal-title":"Haematologica"},{"key":"3974_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky354","author":"J-P Concordet","year":"2018","unstructured":"Concordet J-P, Haeussler M. CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens. Nucleic Acids Res. 2018. https:\/\/doi.org\/10.1093\/nar\/gky354.","journal-title":"Nucleic Acids Res"},{"key":"3974_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2024.03.006","author":"J Klermund","year":"2024","unstructured":"Klermund J, Rhiel M, Kocher T, Chmielewski KO, Bischof J, Andrieux G, et al. On- and off-target effects of paired CRISPR-Cas nickase in primary human cells. Mol Ther. 2024. https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.006.","journal-title":"Mol Ther"},{"key":"3974_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41420-019-0151-0","volume":"5","author":"FV Mello","year":"2019","unstructured":"Mello FV, Land MGP, Costa ES, Teod\u00f3sio C, Sanchez ML, B\u00e1rcena P, et al. Maturation-associated gene expression profiles during normal human bone marrow erythropoiesis. Cell Death Discov. 2019;5:1\u201312. https:\/\/doi.org\/10.1038\/S41420-019-0151-0.","journal-title":"Cell Death Discov"},{"key":"3974_CR36","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/J.BBRC.2007.05.168","volume":"359","author":"S Lee","year":"2007","unstructured":"Lee S, Hwang J, Ulaszek J, Kim YC, Dong H, Kim HS, et al. Stable transcriptional status in the apoptotic erythroid genome. Biochem Biophys Res Commun. 2007;359:556\u201362. https:\/\/doi.org\/10.1016\/J.BBRC.2007.05.168.","journal-title":"Biochem Biophys Res Commun"},{"key":"3974_CR37","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1182\/BLOODADVANCES.2020002539","volume":"5","author":"DCH Chan","year":"2021","unstructured":"Chan DCH, Xu J, Vujovic A, Wong N, Gordon V, De Rooij LPMH, et al. Arhgef2 regulates mitotic spindle orientation in hematopoietic stem cells and is essential for productive hematopoiesis. Blood Adv. 2021;5:3120. https:\/\/doi.org\/10.1182\/BLOODADVANCES.2020002539.","journal-title":"Blood Adv"},{"key":"3974_CR38","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.21037\/TCR-24-1910\/PRF","volume":"14","author":"Y Ye","year":"2025","unstructured":"Ye Y, Fang J, Wang Y, Xu B, Li Z, Chang L, et al. YWHAE affects proliferation, migration and apoptosis of colorectal cancer by regulating extracellular vesicles secretion and Wnt\/\u03b2-catenin signaling pathway. Transl Cancer Res. 2025;14:2260\u201373. https:\/\/doi.org\/10.21037\/TCR-24-1910\/PRF.","journal-title":"Transl Cancer Res"},{"key":"3974_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34493-1","author":"P Antoniou","year":"2022","unstructured":"Antoniou P, Hardouin G, Martinucci P, Frati G, Felix T, Chalumeau A, et al. Base-editing-mediated dissection of a \u03b3-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression. Nat Commun. 2022. https:\/\/doi.org\/10.1038\/s41467-022-34493-1.","journal-title":"Nat Commun"},{"key":"3974_CR40","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1172\/JCI31664","volume":"117","author":"X Yu","year":"2007","unstructured":"Yu X, Kong Y, Dore LC, Abdulmalik O, Katein AM, Zhou S, et al. An erythroid chaperone that facilitates folding of \u03b1-globin subunits for hemoglobin synthesis. J Clin Invest. 2007;117:1856. https:\/\/doi.org\/10.1172\/JCI31664.","journal-title":"J Clin Invest"},{"key":"3974_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PBIO.3002071","author":"EM Porto","year":"2023","unstructured":"Porto EM, Komor AC. In the business of base editors: evolution from bench to bedside. PLoS Biol. 2023. https:\/\/doi.org\/10.1371\/JOURNAL.PBIO.3002071.","journal-title":"PLoS Biol"},{"key":"3974_CR42","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1182\/bloodadvances.2020003702","volume":"5","author":"C Li","year":"2021","unstructured":"Li C, Georgakopoulou A, Mishra A, Gil S, Hawkins RD, Yannaki E, et al. In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal \u03b3-globin in \u03b2-YAC mice. Blood Adv. 2021;5:1122\u201335. https:\/\/doi.org\/10.1182\/bloodadvances.2020003702.","journal-title":"Blood Adv"},{"key":"3974_CR43","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/s41587-020-0527-y","volume":"38","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhu B, Chen L, Xie L, Yu W, Wang Y, et al. Dual base editor catalyzes both cytosine and adenine base conversions in human cells. Nat Biotechnol. 2020;38:856\u201360. https:\/\/doi.org\/10.1038\/s41587-020-0527-y.","journal-title":"Nat Biotechnol"},{"key":"3974_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-01128-4","author":"DE Yoon","year":"2023","unstructured":"Yoon DE, Kim NR, Park SJ, Jeong TY, Eun B, Cho Y, et al. Precise base editing without unintended indels in human cells and mouse primary myoblasts. Exp Mol Med. 2023. https:\/\/doi.org\/10.1038\/s12276-023-01128-4.","journal-title":"Exp Mol Med"},{"key":"3974_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01915-4","author":"M Fiumara","year":"2023","unstructured":"Fiumara M, Ferrari S, Omer-Javed A, Beretta S, Albano L, Canarutto D, et al. Genotoxic effects of base and prime editing in human hematopoietic stem cells. Nat Biotechnol. 2023. https:\/\/doi.org\/10.1038\/s41587-023-01915-4.","journal-title":"Nat Biotechnol"},{"key":"3974_CR46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1182\/BLOOD-2013-09-528067","volume":"123","author":"MH Steinberg","year":"2014","unstructured":"Steinberg MH, Chui DHK, Dover GJ, Sebastiani P, Alsultan A. Fetal hemoglobin in sickle cell anemia: a glass half full? Blood. 2014;123:481\u20135. https:\/\/doi.org\/10.1182\/BLOOD-2013-09-528067.","journal-title":"Blood"},{"key":"3974_CR47","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1101\/GAD.1897310","volume":"24","author":"J Xu","year":"2010","unstructured":"Xu J, Sankaran VG, Ni M, Menne TF, Puram RV, Kim W, et al. Transcriptional silencing of \u03b3-globin by BCL11A involves long-range interactions and cooperation with SOX6. Genes Dev. 2010;24:783\u201398. https:\/\/doi.org\/10.1101\/GAD.1897310.","journal-title":"Genes Dev"},{"key":"3974_CR48","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/J.OMTM.2018.08.003","volume":"10","author":"N Psatha","year":"2018","unstructured":"Psatha N, Reik A, Phelps S, Zhou Y, Dalas D, Yannaki E, et al. Disruption of the BCL11A erythroid enhancer reactivates fetal hemoglobin in erythroid cells of patients with \u03b2-thalassemia major. Mol Ther Methods Clin Dev. 2018;10:313\u201326. https:\/\/doi.org\/10.1016\/J.OMTM.2018.08.003.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"9","key":"3974_CR49","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nm.4170","volume":"22","author":"EA Traxler","year":"2016","unstructured":"Traxler EA, Yao Y, Wang YD, Woodard KJ, Kurita R, Nakamura Y, et al. A genome-editing strategy to treat \u03b2-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition. Nat Med. 2016;22(9):987\u201390. https:\/\/doi.org\/10.1038\/nm.4170.","journal-title":"Nat Med"},{"key":"3974_CR50","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1182\/BLOODADVANCES.2024015574","volume":"9","author":"Y Jang","year":"2025","unstructured":"Jang Y, Feng R, Palmer LE, Mayuranathan T, Yao Y, Mayberry K, et al. BCL11A-deficient human erythropoiesis is impaired in vitro and after xenotransplantation into mice. Blood Adv. 2025;9:2722\u201332. https:\/\/doi.org\/10.1182\/BLOODADVANCES.2024015574.","journal-title":"Blood Adv"},{"key":"3974_CR51","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1023\/B:APPT.0000018805.63663.A5\/METRICS","volume":"9","author":"L Zamai","year":"2004","unstructured":"Zamai L, Burattini S, Luchetti F, Canonico B, Ferri P, Melloni E, et al. In vitro apoptotic cell death during erythroid differentiation. Apoptosis. 2004;9:235\u201346. https:\/\/doi.org\/10.1023\/B:APPT.0000018805.63663.A5\/METRICS.","journal-title":"Apoptosis"},{"key":"3974_CR52","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00439-023-02561-1","volume":"142","author":"JMT Hunt","year":"2023","unstructured":"Hunt JMT, Samson CA, du Rand A, Sheppard HM. Unintended CRISPR-Cas9 editing outcomes: a review of the detection and prevalence of structural variants generated by gene-editing in human cells. Hum Genet. 2023;142:705\u201320. https:\/\/doi.org\/10.1007\/s00439-023-02561-1.","journal-title":"Hum Genet"},{"key":"3974_CR53","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.ymthe.2024.03.006","volume":"32","author":"J Klermund","year":"2024","unstructured":"Klermund J, Rhiel M, Kocher T, Chmielewski KO, Bischof J, Andrieux G, et al. On- and off-target effects of paired CRISPR-Cas nickase in primary human cells. Mol Ther. 2024;32:1298\u2013310. https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.006.","journal-title":"Mol Ther"},{"key":"3974_CR54","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1021\/ACS.BIOCHEM.9B00573","volume":"58","author":"S Park","year":"2019","unstructured":"Park S, Beal PA. Off-target editing by CRISPR-guided DNA base editors. Biochemistry. 2019;58:3727. https:\/\/doi.org\/10.1021\/ACS.BIOCHEM.9B00573.","journal-title":"Biochemistry"},{"key":"3974_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07988-z","volume":"10","author":"P Liang","year":"2019","unstructured":"Liang P, Xie X, Zhi S, Sun H, Zhang X, Chen Y, et al. Genome-wide profiling of adenine base editor specificity by EndoV-seq. Nat Commun. 2019;10:67. https:\/\/doi.org\/10.1038\/s41467-018-07988-z.","journal-title":"Nat Commun"},{"key":"3974_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/NAR\/GKAF281","author":"K Yuan","year":"2025","unstructured":"Yuan K, Xi X, Han S, Han J, Zhao B, Wei Q, et al. Selict-seq profiles genome-wide off-target effects in adenosine base editing. Nucleic Acids Res. 2025. https:\/\/doi.org\/10.1093\/NAR\/GKAF281.","journal-title":"Nucleic Acids Res"},{"key":"3974_CR57","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/S41587-024-02307-Y","volume":"43","author":"M Zhu","year":"2025","unstructured":"Zhu M, Xu R, Yuan J, Wang J, Ren X, Cong T, et al. Tracking-seq reveals the heterogeneity of off-target effects in CRISPR\u2013Cas9-mediated genome editing. Nat Biotechnol. 2025;43:799\u2013810. https:\/\/doi.org\/10.1038\/S41587-024-02307-Y.","journal-title":"Nat Biotechnol"},{"key":"3974_CR58","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1111\/PBI.13838","volume":"20","author":"Y Wu","year":"2022","unstructured":"Wu Y, Ren Q, Zhong Z, Liu G, Han Y, Bao Y, et al. Genome-wide analyses of PAM-relaxed Cas9 genome editors reveal substantial off-target effects by ABE8e in rice. Plant Biotechnol J. 2022;20:1670\u201382. https:\/\/doi.org\/10.1111\/PBI.13838.","journal-title":"Plant Biotechnol J"},{"key":"3974_CR59","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1089\/CRISPR.2019.0006","volume":"2","author":"E Rayner","year":"2019","unstructured":"Rayner E, Durin M-A, Thomas R, Moralli D, O\u2019Cathail SM, Tomlinson I, et al. CRISPR-Cas9 Causes Chromosomal Instability and Rearrangements in Cancer Cell Lines, Detectable by Cytogenetic Methods. CRISPR J. 2019;2:406. https:\/\/doi.org\/10.1089\/CRISPR.2019.0006.","journal-title":"CRISPR J"},{"key":"3974_CR60","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.cell.2008.01.025","volume":"132","author":"SH Orkin","year":"2008","unstructured":"Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell. 2008;132:631\u201344. https:\/\/doi.org\/10.1016\/j.cell.2008.01.025.","journal-title":"Cell"},{"key":"3974_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22073626","volume":"22","author":"PL Papasavva","year":"2021","unstructured":"Papasavva PL, Papaioannou NY, Patsali P, Kurita R, Nakamura Y, Sitarou M, et al. Distinct mirna signatures and networks discern fetal from adult erythroid differentiation and primary from immortalized erythroid cells. Int J Mol Sci. 2021;22:1\u201329. https:\/\/doi.org\/10.3390\/ijms22073626.","journal-title":"Int J Mol Sci"},{"key":"3974_CR62","unstructured":"Addgene: A better way to share science. https:\/\/www.addgene.org\/. Accessed 13 Jun 2024."},{"key":"3974_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgeed.2023.1141618","volume":"5","author":"NY Papaioannou","year":"2023","unstructured":"Papaioannou NY, Patsali P, Naiisseh B, Papasavva PL, Koniali L, Kurita R, et al. High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mrna synthesis. Front Genome Ed. 2023;5:1\u201314. https:\/\/doi.org\/10.3389\/fgeed.2023.1141618.","journal-title":"Front Genome Ed"},{"key":"3974_CR64","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/crispr.2018.0014","volume":"1","author":"MG Kluesner","year":"2018","unstructured":"Kluesner MG, Nedveck DA, Lahr WS, Garbe JR, Abrahante JE, Webber BR, et al. Editr: a method to quantify base editing from sanger sequencing. CRISPR J. 2018;1:239\u201350. https:\/\/doi.org\/10.1089\/crispr.2018.0014.","journal-title":"CRISPR J"},{"key":"3974_CR65","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/crispr.2021.0113","volume":"5","author":"D Conant","year":"2022","unstructured":"Conant D, Hsiau T, Rossi N, Oki J, Maures T, Waite K, et al. Inference of CRISPR edits from sanger trace data. CRISPR J. 2022;5:123\u201330. https:\/\/doi.org\/10.1089\/crispr.2021.0113.","journal-title":"CRISPR J"},{"key":"3974_CR66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-4939-9170-9_3","volume":"1961","author":"EK Brinkman","year":"2019","unstructured":"Brinkman EK, van Steensel B. Rapid quantitative evaluation of CRISPR genome editing by TIDE and TIDER. Methods Mol Biol. 2019;1961:29\u201344. https:\/\/doi.org\/10.1007\/978-1-4939-9170-9_3.","journal-title":"Methods Mol Biol"},{"key":"3974_CR67","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/hgtb.2017.190","volume":"29","author":"CC Loucari","year":"2018","unstructured":"Loucari CC, Patsali P, Van Dijk TB, Stephanou C, Papasavva P, Zanti M, et al. Rapid and sensitive assessment of globin chains for gene and cell therapy of hemoglobinopathies. Hum Gene Ther Methods. 2018;29:60\u201374. https:\/\/doi.org\/10.1089\/hgtb.2017.190.","journal-title":"Hum Gene Ther Methods"},{"key":"3974_CR68","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0009-8981(01)00672-6","volume":"313","author":"CN Ou","year":"2001","unstructured":"Ou CN, Rognerud CL. Diagnosis of hemoglobinopathies: electrophoresis vs. HPLC. Clin Chim Acta. 2001;313:187\u201394. https:\/\/doi.org\/10.1016\/S0009-8981(01)00672-6.","journal-title":"Clin Chim Acta"},{"issue":"6","key":"3974_CR69","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;3(6):1101\u20138. https:\/\/doi.org\/10.1038\/nprot.2008.73.","journal-title":"Nat Protoc"},{"issue":"7","key":"3974_CR70","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671\u20135. https:\/\/doi.org\/10.1038\/nmeth.2089.","journal-title":"Nat Methods"},{"key":"3974_CR71","doi-asserted-by":"publisher","first-page":"1130736","DOI":"10.3389\/FGEED.2023.1130736\/BIBTEX","volume":"5","author":"M Rhiel","year":"2023","unstructured":"Rhiel M, Geiger K, Andrieux G, Rositzka J, Boerries M, Cathomen T, et al. T-CAST: An optimized CAST-Seq pipeline for TALEN confirms superior safety and efficacy of obligate-heterodimeric scaffolds. Front Genome Ed. 2023;5:1130736. https:\/\/doi.org\/10.3389\/FGEED.2023.1130736\/BIBTEX.","journal-title":"Front Genome Ed"},{"key":"3974_CR72","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841\u20132. https:\/\/doi.org\/10.1093\/bioinformatics\/btq033.","journal-title":"Bioinformatics"},{"key":"3974_CR73","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139. https:\/\/doi.org\/10.1038\/nmeth.1923.","journal-title":"Nat Methods"},{"key":"3974_CR74","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky354","author":"J-P Concordet","year":"2018","unstructured":"Concordet J-P, Haeussler M. CRISPOR: intuitive guide selection for CRISPR\/cas9 genome editing experiments and screens. Nucleic Acids Res. 2018. https:\/\/doi.org\/10.1093\/nar\/gky354.","journal-title":"Nucleic Acids Res"},{"key":"3974_CR75","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench JG, Fusi N, Sullender M, Hegde M, Vaimber EW, Donovan KF, et al. Optimized sgrna design to maximize activity and minimize off-target effects of crispr-Cas9. Nat Biotechnol. 2016;34:184\u201391. https:\/\/doi.org\/10.1038\/nbt.3437.","journal-title":"Nat Biotechnol"},{"key":"3974_CR76","doi-asserted-by":"crossref","unstructured":"Papaioannou NY, Patsali P, Klermund J, Papassava PL, Geoffroy A, Koniali L, Naiisseh B, Christou S, Sitarou M, Kleanthous M, Cathomen T, Lederer CW. Functional correction and genome integrity with duplex base editing of \u03b2-thalassemic hematopoietic stem cells. Datasets. Gene Expression Omnibus. 2025. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE307482.","DOI":"10.1186\/s13059-026-03974-7"},{"key":"3974_CR77","doi-asserted-by":"crossref","unstructured":"Papaioannou NY, Patsali P, Klermund J, Papassava PL, Geoffroy A, Koniali L, Naiisseh B, Christou S, Sitarou M, Kleanthous M, Cathomen T, Lederer CW. Functional correction and genome integrity with duplex base editing of \u03b2-thalassemic hematopoietic stem cells. Datasets. European Nucleotide Archive. 2025. https:\/\/www.ebi.ac.uk\/ena\/browser\/view\/PRJNA1321808.","DOI":"10.1186\/s13059-026-03974-7"},{"key":"3974_CR78","doi-asserted-by":"crossref","unstructured":"Papaioannou NY, Patsali P, Klermund J, Papassava PL, Geoffroy A, Koniali L, Naiisseh B, Christou S, Sitarou M, Kleanthous M, Cathomen T, Lederer CW. Functional correction and genome integrity with duplex base editing of \u03b2-thalassemic hematopoietic stem cells. Datasets. European Nucleotide Archive. 2026. https:\/\/www.ebi.ac.uk\/ena\/browser\/view\/PRJEB106504.","DOI":"10.1186\/s13059-026-03974-7"},{"key":"3974_CR79","doi-asserted-by":"crossref","unstructured":"Papaioannou NY, Patsali P, Klermund J, Papassava PL, Geoffroy A, Koniali L, Naiisseh B, Christou S, Sitarou M, Kleanthous M, Cathomen T, Lederer CW. Functional correction and genome integrity with duplex base editing of \u03b2-thalassemic hematopoietic stem cells. Datasets. BioImage Archive. 2025. https:\/\/www.ebi.ac.uk\/biostudies\/bioimages\/studies\/S-BIAD2535.","DOI":"10.1186\/s13059-026-03974-7"},{"key":"3974_CR80","doi-asserted-by":"crossref","unstructured":"Papaioannou NY, Patsali P, Klermund J, Papassava PL, Geoffroy A, Koniali L, Naiisseh B, Christou S, Sitarou M, Kleanthous M, Cathomen T, Lederer CW. Functional correction and genome integrity with duplex base editing of \u03b2-thalassemic hematopoietic stem cells. 2026. Github, https:\/\/github.com\/AG-Boerries\/CAST-Seq.","DOI":"10.1186\/s13059-026-03974-7"},{"key":"3974_CR81","doi-asserted-by":"crossref","unstructured":"Papaioannou NY, Patsali P, Klermund J, Papassava PL, Geoffroy A, Koniali L, Naiisseh B, Christou S, Sitarou M, Kleanthous M, Cathomen T, Lederer CW. Functional correction and genome integrity with duplex base editing of \u03b2-thalassemic hematopoietic stem cells. 2026. Zenodo, https:\/\/zenodo.org\/records\/18151299.","DOI":"10.1186\/s13059-026-03974-7"}],"container-title":["Genome Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13059-026-03974-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-026-03974-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-026-03974-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:35:30Z","timestamp":1772447730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13059-026-03974-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3974"],"URL":"https:\/\/doi.org\/10.1186\/s13059-026-03974-7","relation":{},"ISSN":["1474-760X"],"issn-type":[{"value":"1474-760X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"2 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Fully informed consent was received from all patients involved in the project under Cyprus National Bioethics Committee license number \u0395\u0395\u0392\u039a\/\u0395\u03a0\/2018\/52.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}